Sleep Apnea

Sleep apnea (AP-ne-ah) is a common disorder in which you have one or more pauses in breathing or shallow breaths while you sleep. Breathing pauses can last from a few seconds to minutes. They often...

The Top 100 Drugs

The pharmaceutical industry is massive, both in range of products and in financial values. These are the top 200 drugs (ranked in descending order according to total sales in 20010, $), and the co...

FDA Rejects Endo Petition To Protect Its Opana Painkiller

The FDA rejected a citizen petition filed by Endo Pharmaceuticals which hoped to protect its Opana painkiller franchise by convincing the agency to require generics to be similarly abuse deterrent as...

Endo Pharmaceuticals Announces Reformulated Version of OPANA ER With INTAC Technology Designed to Be Crush-Resistant Accounts for More Than 90 Percent of Opana ER Total Prescription Volume

Endo submits Citizen Petitions calling for future generics of OPANA ER to be held to the same crush-resistant development standards CHADDS FORD, Pa., September 06, 2012, 2012 /PRNewswire/ -- Endo Phar...

FDA Allows Opana Generics

(MedPage Today) -- The original formulation of extended-release oxymorphone (Opana ER) that lacked abuse-resistant mechanisms was not pulled from the market for safety reasons, and therefore generics...

Coming In Tuesday's "The Pink Sheet" DAILY - Endo Seeks To Block Generic Versions Of Opana ER

Endo files citizen petition opposing approval of ANDAs referencing Opana ER - FDA panel to review technologies for finding adventitious agents in vaccines

Endo Health Solutions - Opana Story De-Emphasized, Buyout Re-Emphasized

ByPropThink: By Jake King A price target reduction from RBC Capital Markets took $1.06 (or 3.4%) out of Endo Health Solutions (ENDP) Thursday, noting risks to the company's pain product, Opana ER. A...

FDA Rejects Endo’s Deadline On Opana ER Petition; Impax Product May Become New RLD

Endo files suit against FDA seeking preliminary injunction to require FDA to say whether Endo’s withdrawal of non-crush resistant Opana ER was for safety reasons; FDA contends it has until May 10, 2...

Abuse of 'New' Opana Linked to Blood Disorder

(MedPage Today) -- Drug users who inject the new "abuse-deterrent" version of Opana ER (oxymorphone) may be at risk of developing a serious blood disease, according to Tennessee health officials.

Impax begins patent challenge over Opana ER generic version

America's Impax Laboratories has begun the challenging process against the suit filed by two companies for patent infringement over a generic version of Opana® ER (oxymorphone hydrochloride extended-...

Extrapleural Hematomas: Imaging Appearance, Classification, and Clinical Significance.

PURPOSE: We sought to identify radiologic and clinical findings associated with extrapleural hematomas (EPHs), to formulate an imaging-based classification system for EPHs, and to identify any radiolo...

A geometrical model of vertical translation and alar ligament tension in atlanto-axial rotation.

INTRODUCTION: While allowing the greatest range of axial rotation of the entire spine with 40° to each side, gradual restraint at the extremes of motion by the alar ligaments is of vital importance....

Discretely tunable optofluidic compound microlenses.

We report a novel method to fabricate high zoom-ratio optofluidic compound microlenses using poly(dimethylsiloxane) with multi-layer architecture. The layered structure of deformable lenses, biconvex...

Benign Anterior Temporal Epidural Hematoma: Indolent Lesion with a Characteristic CT Imaging Appearance after Blunt Head Trauma.

Purpose: To study the incidence, pathogenesis, imaging characteristics, and clinical importance of a unique subtype of epidural hematoma (EDH) associated with blunt head trauma. Materials and Methods:...